Jones Financial Companies
NUVB icon

Jones Financial Companies’s Nuvation Bio NUVB Stock Holding History

Jones Financial Companies’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$22.1K Buy
5,200
+200
+4% +$1.11K ﹤0.01% 3258
2025
Q4 		$44.8K Buy
5,000
+1,000
+25% +$6.19K ﹤0.01% 2580
2025
Q3 		$12.8K Buy
+4,000
New +$10.9K ﹤0.01% 2987
2025
Q2 		– Sell
-16,842
Closed -$30.7K – 4132
2025
Q1 		$30.7K Buy
+16,842
New +$38.3K ﹤0.01% 2258

Other funds holding NUVB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $661M AUM 299.97% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
DFO
Duquesne Family Office New York $3.38B AUM 61.92% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Jones Financial Companies's NUVB Position: Q1 2026 in Review

Jones Financial Companies increased its Nuvation Bio (NUVB) stake by 4% in Q1 2026, buying an estimated $1.11K and bringing the position to 5,200 shares worth $22.1K. The position accounts for ﹤0.01% of the portfolio, ranked #3258.

Jones Financial Companies first reported a position in NUVB in Q1 2025 and has held it in 4 quarters since. The position peaked at $44.8K in Q4 2025. 231 funds tracked by Wall St. Rank hold NUVB as of Q1 2026.

  • Jones Financial Companies held 5,200 shares of Nuvation Bio worth $22.1K as of Q1 2026.
  • Jones Financial Companies bought 200 Nuvation Bio shares in Q1 2026, an estimated $1.11K.
  • Nuvation Bio made up ﹤0.01% of Jones Financial Companies's portfolio in Q1 2026, its #3258 holding.
  • Jones Financial Companies first reported a position in Nuvation Bio in Q1 2025 and has held it in 4 quarters since.
  • Jones Financial Companies's Nuvation Bio position peaked at $44.8K in Q4 2025.
  • 231 funds tracked by Wall St. Rank held Nuvation Bio as of Q1 2026.

Based on Jones Financial Companies's 13F filing for Q1 2026, filed 15 May 2026.